Abstract / descriptionThis study aimed to determine the effect of thioredoxin on the immunogenicity of the recombinant P32 (rP32) protein of LSD virus lumpy skin disease
Abstract / descriptionThis study aimed to evaluate the pathogenicity, immunogenicity, and virus load of nVarIBDV in organs of specific-pathogen-free (SPF) chickens.
This study assessed the immunogenicity, safety, and protective effectiveness of a native ~34 kDa Omp34 (nOmp34) subunit vaccine in BALB/c mice, comparing it to a formalin-killed cell (FKC) vaccine, and examined immune factors that may predict survival.
Abstract / descriptionThis study assessed the immunogenicity, safety, and protective effectiveness of a native ~34 kDa Omp34 (nOmp34) subunit vaccine in BALB/c mice, comparing it to a formalin-killed cell (FKC) vaccine, and examined immune factors that may predict survival.
This study aimed to produce PEDV-specific hyperimmune colostrum and milk from goats and evaluate the safety and immunogenicity of live-attenuated and inactivated PEDV vaccines.
Abstract / descriptionThis study aimed to produce PEDV-specific hyperimmune colostrum and milk from goats and evaluate the safety and immunogenicity of live-attenuated and inactivated PEDV vaccines.
Abstract / descriptionThis study aimed to attenuate, molecularly characterize, and determine the immunogenicity, efficacy, and challenge virus shedding in broiler chickens.
Abstract / descriptionThis study aimed to produce a vaccine against alpha-toxin using C. perfringens type A (ATCC 13124) and investigate its potency, stability, and safety
This study aimed to develop an inactivated oil-adjuvanted vaccine using a local LSDV isolate and evaluate its immunogenicity and protective efficacy in rabbits.
Abstract / descriptionThis study aimed to develop an inactivated oil-adjuvanted vaccine using a local LSDV isolate and evaluate its immunogenicity and protective efficacy in rabbits.
Abstract / descriptionThis study aimed to measure the FMD virus (FMDV)-specific responses in cattle and sheep after a single dose of a trivalent FMD vaccine
This study evaluated the safety, immunogenicity, and protective efficacy of a novel influenza vector-based vaccine expressing M. bovis antigens ESAT-6 and TB10.4, formulated with or without an adjuvant.
Abstract / descriptionThis study evaluated the safety, immunogenicity, and protective efficacy of a novel influenza vector-based vaccine expressing M. bovis antigens ESAT-6 and TB10.4, formulated with or without an adjuvant.